Navigation Links
Align Technology to Announce First Quarter Fiscal 2009 Results on April 23, 2009
Date:4/2/2009

SANTA CLARA, Calif. April 2 /PRNewswire-FirstCall/ -- Align Technology, Inc. (Nasdaq: ALGN), the inventor of Invisalign(R), announced today that the Company will report first quarter 2009 financial results on Thursday, April 23, 2009 after the close of market. Financial results will be released over PR Newswire and First Call and will be available on the Investor Relations section of the Company's website at http://investor.aligntech.com.

Following the press release, the Company will host a conference call to discuss its financial results. The conference call will begin at 4:30 p.m. ET (1:30 p.m. PT) and will also be available as an audio web cast live via the Internet. To access the web cast, please visit the Investor Relations section of Align Technology's website at http://investor.aligntech.com. To access the conference call, please dial 201-689-8341 approximately fifteen minutes prior to the start of the call.

If you are unable to listen to the call, an archived web cast will be available beginning approximately one hour after the call's conclusion and will remain available for approximately 12 months. Additionally, a telephonic replay of the call can be accessed by dialing 877-660-6853 with account number 292 followed by # and conference number 318996 followed by #. The replay must be accessed from international locations by dialing 201-612-7415 and using the same account and conference numbers referenced above. The telephonic replay will be available through 5:30 p.m. ET on May 06, 2009.

About Align Technology, Inc.

Align Technology designs, manufactures and markets Invisalign, a proprietary method for treating malocclusion, or the misalignment of teeth. Invisalign corrects malocclusion using a series of clear, nearly invisible, removable appliances that gently move teeth to a desired final position. Because it does not rely on the use of metal or ceramic brackets and wires, Invisalign significantly reduces the aesthetic and other limitations associated with braces. Invisalign is appropriate for treating adults and teens. Align Technology was founded in March 1997 and received FDA clearance to market Invisalign in 1998. Today, the Invisalign product family includes Invisalign, Invisalign Teen, Invisalign Assist, Invisalign Express, and Vivera Retainers.

To learn more about Invisalign or to find a certified Invisalign doctor in your area, please visit www.invisalign.com or call 1-800-INVISIBLE.

    Investor Relations Contact
    Shirley Stacy
    Align Technology, Inc.
    (408) 470-1150
    sstacy@aligntech.com

    Press Contact
    Shannon Mangum Henderson
    Ethos Communication, Inc.
    (678) 540-9222
    align@ethoscommunication.com


'/>"/>
SOURCE Align Technology, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. NovaLign(TM) Orthopaedics, Inc. Announces its First 510(K) Clearance From the FDA for New Intramedullary Fixation System
2. Poniard Pharmaceuticals to Focus Company Resources on Late-Stage Oncology Candidate Picoplatin Through Realignment of Research Organization
3. Dr. James F. Pingpank to Present at the Sixth International Symposium on Melanoma and Other Cutaneous Malignancies on March 13- 14, 2009 in New York City
4. A new measure for the malignancy of melanoma
5. Align Technology Names Sheila Tan as VP, Marketing and Chief Marketing Officer
6. Precyse Solutions Adds Executives, Realigns Around Service Lines
7. Align Technology Announces International Availability of Invisalign Teen(TM)
8. EMSI Realigns Internal Divisions for More Effective Focus on Customers
9. Video: The MDS Foundation Says Published Data Confirms VIDAZA(R) Significantly Extends Survival in Patients with the Malignant Condition MDS
10. Align Technology Asserts ClearCorrect Complaint Is Without Merit
11. Biomarker Combination and Risk of Ovarian Malignancy Algorithm (Roma(TM)) Demonstrates Accuracy in Detecting Ovarian Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... ... 2016 , ... The Bank of America Charitable Foundation has awarded a grant ... a pathway to employment and successful careers in healthcare. On Wednesday, May 4th, Rick ... and CEO of Medisend, parent organization and home of the General Myers Veterans Program. ...
(Date:5/25/2016)... ... ... Dr. Travis Schwarz is an experienced dentist who leads Riverheart Family ... serves patients of all ages with a full menu of dental services, including preventative, ... the superior patient reviews that he has consistently earned during his practice experience. It ...
(Date:5/25/2016)... (PRWEB) , ... May 25, 2016 , ... Cheryl Bowker ... has to bestow: the Dick McKenna Good Hands Legacy Award. McKenna ran one of ... others which continues to inspire all those who knew him. The award named for ...
(Date:5/25/2016)... Coral Gables, FL (PRWEB) , ... May 25, ... ... in its Cross Benefit Clearinghouse supporting the real time adjudication of medical service ... Urgent Care providers using their current medical claims management software. The TransactRx Cross ...
(Date:5/25/2016)... ... May 25, 2016 , ... America Walks , a national advocacy ... of the University of Pittsburgh Graduate School of Public Health , has been ... and 24 other advocates from around the country to participate in a four-month training ...
Breaking Medicine News(10 mins):
(Date:5/23/2016)... WASHINGTON , May 23, 2016 The World ... PrePex device to include adolescents aged 13 years, ... MedTech, can be offered for adult and adolescent males in ... Africa . PrePex was the first male circumcision device ... Circ MedTech,s CEO, Eddy Horowitz said: " The ...
(Date:5/23/2016)... Gamida Cell, a leader in ... and orphan genetic diseases, announced today it has been ... the Israel Innovation Authority (formerly the Office of the ... Industry. The mission of the Israel Innovation Authority is ... science and technology, while stimulating economic growth. ...
(Date:5/22/2016)... DUBLIN , May 23, 2016 ... to develop its anti-fibrotic and anti-inflammatory compound DS102 ... well as in non-alcoholic steatohepatitis (NASH) patients. ... is significantly sequestered in lung tissue and has ... tissue after oral administration. The Company will publish ...
Breaking Medicine Technology: